Search research articles
Contact Us
Filters
Showing results (111-120 of 323) with videos related to
Page
of 33
Sort By:
Arthritis Care & Research
|
June 18, 2025
Time Trends and Predictors of Gout Remission Over 6 Years
Adwoa Dansoa Tabi-Amponsah, Sarah Stewart, Greg Gamble, et al.
Internal Medicine Journal
|
April 16, 2025
Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand
Hamish J Farquhar, Tania Huria, Lutz Beckert, et al.
Internal Medicine Journal
|
August 31, 2016
Incidence of anti-neutrophil cytoplasmic antibody-associated vasculitis before and after the February 2011 Christchurch Earthquake
H J Farquhar, B McGettigan, P T Chapman, et al.
The Lancet. Rheumatology
|
February 7, 2022
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study
Ruth K Topless, Angelo Gaffo, Lisa K Stamp, et al.
Annals of the Rheumatic Diseases
|
June 19, 2025
The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in gout
Adwoa Dansoa Tabi-Amponsah, Sarah Stewart, Lisa K Stamp, et al.
Arthritis Care & Research
|
December 23, 2024
Gout Flares After Stopping Anti-Inflammatory Prophylaxis: A Rapid Literature Review and Meta-Analysis
Lisa K Stamp, Christopher Frampton, Jeff A Newcomb, et al.
The Journal of Rheumatology
|
November 15, 2024
Association of Past Smoking Status With Gout in Māori People in Aotearoa New Zealand
Niamh C Fanning, John F Pearson, Nicola Dalbeth, et al.
Arthritis and Rheumatism
|
May 18, 2013
Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial
Lisa K Stamp, John L O'Donnell, Christopher Frampton, et al.
Rheumatology (Oxford, England)
|
January 1, 2020
Lack of effect of tart cherry concentrate dose on serum urate in people with gout
Lisa K Stamp, Peter Chapman, Christopher Frampton, et al.
Pharmacogenetics and Genomics
|
June 8, 2015
A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout
Rebecca L Roberts, Mary C Wallace, Andrew Harrison, et al.
Page
of 33
Search research articles
Search
Showing results (111-120 of 323) with videos related to
Sort By:
Page
of 33
Arthritis Care & Research
|
June 18, 2025
Time Trends and Predictors of Gout Remission Over 6 Years
Adwoa Dansoa Tabi-Amponsah, Sarah Stewart, Greg Gamble, et al.
Internal Medicine Journal
|
April 16, 2025
Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand
Hamish J Farquhar, Tania Huria, Lutz Beckert, et al.
Internal Medicine Journal
|
August 31, 2016
Incidence of anti-neutrophil cytoplasmic antibody-associated vasculitis before and after the February 2011 Christchurch Earthquake
H J Farquhar, B McGettigan, P T Chapman, et al.
The Lancet. Rheumatology
|
February 7, 2022
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study
Ruth K Topless, Angelo Gaffo, Lisa K Stamp, et al.
Annals of the Rheumatic Diseases
|
June 19, 2025
The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in gout
Adwoa Dansoa Tabi-Amponsah, Sarah Stewart, Lisa K Stamp, et al.
Arthritis Care & Research
|
December 23, 2024
Gout Flares After Stopping Anti-Inflammatory Prophylaxis: A Rapid Literature Review and Meta-Analysis
Lisa K Stamp, Christopher Frampton, Jeff A Newcomb, et al.
The Journal of Rheumatology
|
November 15, 2024
Association of Past Smoking Status With Gout in Māori People in Aotearoa New Zealand
Niamh C Fanning, John F Pearson, Nicola Dalbeth, et al.
Arthritis and Rheumatism
|
May 18, 2013
Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial
Lisa K Stamp, John L O'Donnell, Christopher Frampton, et al.
Rheumatology (Oxford, England)
|
January 1, 2020
Lack of effect of tart cherry concentrate dose on serum urate in people with gout
Lisa K Stamp, Peter Chapman, Christopher Frampton, et al.
Pharmacogenetics and Genomics
|
June 8, 2015
A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout
Rebecca L Roberts, Mary C Wallace, Andrew Harrison, et al.
Page
of 33